Background: Severe hypoxemia is a major complication of chronic obstructive pulmonary disease (COPD). Long-term oxygen therapy is beneficial in hypoxemic COPD patients. However, the clinical and radiographic predictors of hypoxemia and the use of oxygen therapy are not well described. This study aimed to find the correlates of resting hypoxemia and the pattern of oxygen use in moderate to severe COPD patients. Methods: Subjects with GOLD stage II or higher COPD from the first 2500 COPDGene subjects were included in this analysis. All subjects were current or ex-smokers between ages 45 and 80. Severe resting hypoxemia was defined as room air oxygen saturation (SpO 2 ) 88%. Use of supplemental oxygen therapy was determined by questionnaire. Results: Eighty-two of 1060 COPD subjects (7.7%) had severe resting hypoxemia. Twenty-one of the 82 (25.6%) were not using continuous supplemental oxygen. Female sex, higher BMI, lower FEV 1 , and enrollment in Denver were independent risk factors for hypoxemia; emphysema severity on quantitative chest CT scan did not predict hypoxemia. 132 of 971(13.6%) subjects without severe resting hypoxemia were using continuous supplemental oxygen.
Introduction
Hypoxemia in chronic obstructive pulmonary disease (COPD) results from physiologic derangements such as airflow limitation, ventilationeperfusion imbalance, loss of lung parenchyma, and remodeling and destruction of the pulmonary vasculature. Lung function, specifically the forced expiratory volume in 1 s (FEV 1 ), is correlated with arterial oxygenation in COPD. 1 Nevertheless, some patients suffer from hypoxemia with relatively preserved lung function while other patients maintain normal oxygen levels despite advanced COPD. This suggests that there are other factors which contribute to hypoxemia, besides impaired lung mechanics.
Chronic hypoxemia is a strong predictor of mortality in COPD. 2, 3 Long-term oxygen treatment (LTOT) is known to improve survival in COPD patients with severe resting hypoxemia. 4, 5 Although the criteria for LTOT prescription are well-established, there are few reports on the actual patterns of LTOT usage, including the factors which affect the pattern of LTOT use in hypoxemic COPD patients, and the use of supplemental oxygen therapy in non-hypoxemic COPD patients. Therefore, we sought to identify the determinants besides hypoxemia that may affect the actual pattern of oxygen use in COPD, including emphysema severity, exercise capacity, and quality of life, in a large cohort of moderate to very severe COPD patients enrolled in the COPDGene Study.
Materials and methods

Study subjects
The Genetic epidemiology of COPD (COPDGene Ò ) Study is a multicenter observational study, recruiting COPD cases and smoking controls, who were non-Hispanic whites and AfricaneAmericans ages 45 to 80 with at least 10 pack-years of smoking history. Study procedures have been described elsewhere. 6 Among the first 2500 subjects (April 2010 COPDGene data set) recruited at 18 clinical centers including Denver (altitude 5280 ft.), COPD subjects in GOLD Stage II or greater (post-bronchodilator FEV 1 <80% predicted with FEV 1 / FVC<0.7) were included in this analysis. Informed consent was obtained from all subjects, and the study was approved by institutional review boards at all participating centers (Partners Healthcare IRB, # 2007P000554).
Study procedures
Spirometry was performed before and after inhalation of 2 puffs of albuterol according to American Thoracic Society (ATS) criteria. 7 Questionnaires included a modified version of the ATS Respiratory Epidemiology Questionnaire, demographic information, medications, medical history, and the St George's Respiratory Questionnaire (SGRQ). 8 The time of usage and average daily duration of supplemental oxygen therapy were determined by questionnaire.
Oxygen saturation by pulse oximeter (SpO 2 ) was recorded after the subject had remained at rest in the seated position for at least 5 min. The pulse oximeter was placed on a finger without nail polish and the reading was considered valid only if a strong pulse was demonstrable. The median value was obtained while observing the monitor over a 1-min period. In subjects using supplemental oxygen, the subject's oxygen was discontinued while monitoring the oximeter for a period of 5 min. 9 The apparent median value obtained while observing the monitor over a 1-min observation period was recorded. If the pulse oximeter reading fell to 82% or less, oxygen was replaced and a reading of 82% was recorded as the subject's SpO 2.
CT imaging
Each subject underwent an inspiratory chest CT with a radiation dose of 200 mAs and an expiratory chest CT at 50 mAs. Percent of emphysema (% of lung <À950 HU) on the inspiratory CT scan, and gas trapping (% of lung <À856 HU) on the expiratory CT scan were calculated using 3D-SLICER software (http://www.slicer.org). 10, 11 Total lung capacity (TLC) was also determined using 3D-SLICER software. Predicted value for TLC was computed from the equations of Crapo et al. 12 Airway wall area was estimated as the square root of airway wall area for a hypothetical 10 mm luminal perimeter (Pi 10 ) airway using VIDA software. 13, 14 For this paper, CT images of hypoxemic cases with GOLD stage II COPD were reviewed independently by a chest radiologist (FLJ) and a pulmonologist (DKK) using the COPDGene CT assessment form (http://www.copdgene.org/). Discrepancies were resolved by discussion.
Statistical analysis
Severe resting hypoxemia was defined by SpO 2 88%. 'Continuous' oxygen therapy was defined when a patient stated that he/she used oxygen at rest, with activity and during sleep. 'Intermittent' oxygen therapy was defined when a subject was using oxygen only during exercise and/ or sleep.
Univariate analyses used the chi-square test or Fisher's exact test for categorical variables and the student t-test for continuous variables. CochraneArmitage trend test was used for categorical variables. Logistic regression was applied for analyses of binary outcomes, while linear regression analysis was applied for resting SpO 2 as a quantitative outcome. Statistical analysis used SAS (version 9.1) and statistical significance was determined by p < 0.05.
Results
Characteristics of hypoxemic and non-hypoxemic COPD patients
One thousand and sixty-one COPD cases were included in the analysis ( Compared with cases enrolled at lower altitude centers, patients recruited in Denver showed lower resting SpO 2 , more severe airflow obstruction and higher severity of emphysema (Supplementary Table 1 ). In multivariate analysis, recruitment in Denver was associated with lower FEV 1 (%predicted) and higher TLC as well as lower oxygen saturation. Enrollment in Denver was not associated with 6-min walk distance, SGRQ score and severity of emphysema and gas trapping on volumetric chest CT (Supplementary Table 2 ).
The patients recruited in Denver comprised the majority of the hypoxemic group (84.2%) and their mean saturation was 90.5 AE 4.3%, which was significantly lower than 95.6 AE 2.5% in the non-Denver cases (p < 0.0001). Women were more common and current smokers were less common among the hypoxemic patients, including those in Denver. Hypoxemic patients showed more severe airflow obstruction and greater limitation in exercise capacity. On quantitative chest CT scan analysis, the extent of emphysema and gas trapping were higher in the hypoxemic group.
Predictors of severe resting hypoxemia in COPD patients
Because of the large proportion of hypoxemic cases enrolled in Denver, the multivariate analyses were done after stratifying the population by study center ( Table 2 ). In a logistic regression model, female gender, higher BMI, and decreasing FEV 1 were independent risk factors for hypoxemia in all subjects; age was significant only in Denver subjects. In the quantitative analysis of SpO 2 , age, BMI, and FEV 1 were significant predictors in Denver subjects and all subjects. BMI was positively correlated with FEV 1 (r Z 0.17, p < 0.0001) and negatively with percent of emphysema (r Z À0.37, p < 0.0001), yet higher BMI rather than lower BMI was a predictor of severe resting hypoxemia. The plausible explanation is that the characteristics of our study population may be different from those of previous reports which focused on COPD subjects with low BMI.
15e17 The mean value of BMI in this population was 28.0 AE 6.2 kg/m 2 , which was higher than in other studies. 15e17 In addition, an increased prevalence of obesity or overweight (BMI !28 kg/ m 2 ) has also been reported in patients with chronic bronchitis. 18, 19 Although only a limited proportion of subjects (848/1060 cases, 80.0%) were evaluated for the airway wall thickness (Pi10) on chest CT, we found that the mean value was increased in subjects with high BMI compared to subjects with lower BMI (3.78 AE 0.11 vs. 3.82 AE 0.14, p < 0.0001). This may suggest that subjects with higher BMI contained patients with airway disease but more mild emphysema, and it also reflects the minor contribution of emphysema severity to the development of resting hypoxemia in overweight or obese COPD patients. Fifteen cases with GOLD II COPD (mean FEV 1 % predicted 60.8 AE 8.6%) were found to have resting hypoxemia; 11 cases were recruited in Denver. On quantitative CT scan analysis, 10 cases showed significant extent of emphysema (range 10.7%e34.7%) and another 3 cases showed severe gas trapping (range 20.9e36.2%) despite no evidence of prominent emphysema. Two cases had no significant abnormality on review of chest CT scan by two independent readers, but they were obese with BMIs of 36.1 and 36.3 kg/m 2 . There was no evidence of clinically significant interstitial lung disease or enlargement of cardiac size on these 15 chest CTs (Supplementary Table 3 ). The extent of emphysema by computerized analysis was higher in these 15 cases than in 513 non-hypoxemic cases with GOLD stage II COPD (13.5 AE 8.8% vs. 8.7 AE 8.2%, p Z 0.03).
In linear regression analysis for resting SpO 2 , age, white race, higher BMI, and lower FEV 1 were independent risk factors for decreasing SpO 2 in all subjects (Table 2) . Race was not significant in Denver subjects, but female gender was significant. In both multiple regression models, CT emphysema severity was not a significant predictor of hypoxemia or lower resting oxygen saturation. Emphysema severity did not improve the prediction of hypoxemia over FEV 1 alone.
Use of supplemental oxygen in COPD patients
Twenty-one of 82 patients with severe resting hypoxemia (25.6%) at the time of the study visit were not using continuous oxygen; 13 subjects reported using oxygen during exercise and/or sleep, and 8 did not report any use of oxygen therapy. Surprisingly, 132 of 971 patients without severe resting hypoxemia (13.6%) were using continuous oxygen therapy. An additional 122 cases without severe resting hypoxemia (12.6%) were using oxygen only during exercise and/or sleep. The majority of subjects using oxygen therapy without severe resting hypoxemia had oxygen saturations that were clearly in the non-hypoxemic range (Fig. 2) . However, the proportion of non-hypoxemic cases using oxygen therapy increased with increasing GOLD stage (Fig. 1) .
Compared with hypoxemic subjects not using continuous oxygen, hypoxemic subjects using oxygen continuously at rest had lower SpO 2 ( Fig. 3) and were more commonly men (Table 3) . Patients enrolled in Denver comprised most of hypoxemic subjects using continuous supplemental oxygen. There was no difference in age, race, BMI, level of education, and pack-years of smoking between hypoxemic COPD subjects who were or were not using continuous oxygen.
Among the non-hypoxemic subjects, subjects using continuous oxygen had lower SpO 2 than subjects who were not using supplemental oxygen (Fig. 3) . There was no difference in SpO 2 between intermittent and continuous oxygen users without resting hypoxemia. The group using oxygen continuously was older and included more cases recruited from Denver and more ex-smokers compared with non-hypoxemic COPD cases not using oxygen.
In both the hypoxemic and non-hypoxemic groups, subjects using oxygen continuously showed more severe symptoms, including a higher MMRC dyspnea scale, shorter 6MWD, and higher SGRQ score, and more severe airflow obstruction ( Table 4) .
Predictors of continuous oxygen use in hypoxemic COPD patients
In multivariate analysis (Table 5) , enrollment in Denver and severe dyspnea were independent predictors for continuous use of oxygen in hypoxemic COPD patients. Women were less likely to use continuous oxygen. The severity of airflow obstruction was not an independent risk factor for continuous oxygen use. Neither extent of emphysema nor gas trapping on chest CT predicted continuous use of oxygen in hypoxemic COPD patients. In a model with the same covariates, replacing SGRQ score or 6MWD for MMRC dyspnea scale, higher SGRQ score and shorter 6MWD were independent predictors for the continuous use of oxygen (Supplementary Table 4 ).
Predictors of oxygen use in non-hypoxemic COPD patients
Comparing the non-hypoxemic COPD patients who used oxygen continuously vs. intermittently, higher BMI and lower FEV 1 as well as more severe dyspnea were significant predictors for the continuous use of oxygen (Table 5 Table 4 ). Figure 1 The proportion of cases using oxygen therapy (continuously or intermittently) according to the presence of severe hypoxemia (SpO 2 88%) and the severity of COPD (GOLD stage). Figure 2 The distribution of room air oxygen saturation among COPD subjects without severe resting hypoxemia who were using supplemental oxygen.
Comparing non-hypoxemic COPD patients who were and were not using supplemental oxygen, decreasing SpO 2 , older age, female gender, AfricaneAmerican race, enrollment from Denver, higher BMI, ex-smoker status, lower FEV 1 , greater CT emphysema, and severe dyspnea were significant predictors of oxygen use (Table 5 ). Higher SGRQ score and shorter 6MWD were also predictors for using oxygen in this group (Supplementary Table 4 ).
Discussion
In a large study of COPD subjects representing a range of disease severity, we found that female gender, high altitude, and decreased lung function contributed to the presence of severe hypoxemia, while emphysema did not affect severe resting hypoxemia. Both overuse and underuse of LTOT were common. More than 25% of severely hypoxemic COPD patients were not using continuous oxygen, while 13.5% of moderate to very severe COPD cases without severe resting hypoxemia reported continuous oxygen use. Both dyspnea and exercise capacity were significant predictors for continuous oxygen use, whereas resting SpO 2 and CT emphysema severity did not predict oxygen use.
Subjects enrolled in Denver, Colorado comprised the majority of those with severe resting hypoxemia. Colorado has one of the highest COPD mortality rates in the U.S., and high altitude has been suggested as a possible cause. 20, 21 The resting oxygen saturation in cases enrolled in Denver was significantly lower than that of the cases in other centers even after adjusting for other COPD severity measures, which reflects the effect of high altitude on oxygen saturation. In addition to altitude, female gender, higher BMI and lower FEV 1 were risk factors for severe resting hypoxemia while the severity of emphysema on CT does not predict resting hypoxemia or lower oxygen saturation. Emphysema has been reported a pathologic process resulting in decreasing diffusing capacity in COPD 22 and arterial desaturation during exercise. 23, 24 However, radiographic severity of emphysema was not a risk factor for resting hypoxemia in this study group. It suggests that simple emphysema severity on chest CT may not be a good indicator in assessing hypoxemic status of COPD patients at rest, which results from complicated physiologic derangements including airflow limitation, ventilationeperfusion imbalance, loss of lung parenchyma, and remodeling and destruction of the pulmonary vasculature. Measurement of diffusing capacity may help address these issues, but diffusing capacity measurements were not available in COPDGene.
Surprisingly, 15 cases with GOLD stage II COPD were found to have severe resting hypoxemia. However, majority (86.7%) showed definite emphysema and/or gas trapping on chest CT. Eleven of 15 cases were recruited from Denver. Therefore, the combined effects of high altitude and severe emphysema or gas trapping may yield hypoxemia despite relatively preserved lung function, although emphysema was not a risk factor for severe resting hypoxemia in the total population. Figure 3 Resting oxygen saturation according to the groups defined by hypoxemia and oxygen use. Group 1: Hypoxemic COPD subjects using continuous supplemental oxygen therapy; Group 2: Hypoxemic COPD subjects using supplemental oxygen therapy with exercise and/or sleep only or not using supplemental oxygen therapy; Group 3: Non-hypoxemic COPD subjects using continuous supplemental oxygen therapy; Group 4: Non-hypoxemic COPD subjects using supplemental oxygen therapy with exercise and/or sleep only; Group 5: Non-hypoxemic COPD subjects not using supplemental oxygen therapy.
Although COPDGene is not a population-based sample, LTOT use in COPDGene subjects may reflect the actual usage of supplemental oxygen therapy in COPD patients in the U.S. In patients without severe resting hypoxemia, more than a quarter were using supplemental oxygen, and over half of these subjects were using it more than 20 h per day. The National Emphysema Treatment Trial (NETT) found that more than a third of severe COPD patients without severe resting hypoxemia were using supplemental oxygen, 25 and our report extends this finding to subjects with a broader range of COPD severity. Non-hypoxemic subjects may be prescribed for LTOT for hypoxemia at the time of hospital discharge following an acute exacerbation. Some of these patients may have continued to use oxygen after recovery from the acute exacerbation, despite improvement in resting oxygen saturation. There are reports that only 35e65% of patients prescribed LTOT for an acute exacerbation may be reassessed for the need for LTOT in stable condition. 26 Among non-hypoxemic subjects, cases with a history of an ER visit or hospitalization during the past year were more likely to be using oxygen continuously.
Exercise intolerance was a predictor of oxygen use in COPD cases. Oxygen supplementation during exercise has been reported to improve exercise tolerance in COPD patients who are not hypoxemic at rest. 27, 28 We could not address this indication in our study, since exercise oximetry data were not collected in COPDGene. Considering the frequency of oxygen use in non-hypoxemic COPD patients, a risk-benefit analysis of the use of oxygen in normoxemic COPD patients should be performed, given the finding in NETT that non-hypoxemic subjects receiving continuous supplemental oxygen had increased mortality. 25 Our study found distinct determinants of continuous oxygen use in hypoxemic and non-hypoxemic COPD patients. Even though the indication for LTOT is the presence of severe hypoxemia, resting oxygen saturation was not a determinant of oxygen use when hypoxemic and nonhypoxemic subjects were considered separately. We also found that traditional indicators for the severity of COPD such as FEV 1 , BMI and quantitative CT emphysema were determinants of continuous oxygen use in non-hypoxemic subjects, but not in hypoxemic COPD cases. Instead, severe dyspnea was more strongly related to LTOT use among hypoxemic patients. Hypoxemic subjects using continuous oxygen showed higher TLC than those of subjects using oxygen inadequately. Hyperinflation may influence functional impairment more than reduced FEV 1 or emphysema severity in this group.
Despite these findings, this study has several limitations. Although COPDGene is the one of the largest studies of COPD patients in the U.S., the relatively small number of hypoxemic cases may reduce the power to identify relevant predictors for hypoxemia. Arterial blood gas measurements were not available in COPDGene, though oxygen saturation is generally an accurate indicator of hypoxemia and is the more common test for oxygen prescription in the U.S. Also, the COPDGene study did not collect information on medical insurance status, which might affect patterns of oxygen prescription and use. Although we collected information about actual oxygen use, actual oxygen prescriptions were not determined. Therefore, we could not assess adherence to prescribed oxygen. Without oximetry measurements during exercise or sleep, we were unable to assess whether the use of oxygen during exercise and sleep by patients without resting hypoxemia was appropriate.
In the COPDGene Study, we found that high altitude, female gender and higher BMI predicted severe resting hypoxemia in patients with moderate to very severe COPD; however, emphysema was not significantly associated with severe resting hypoxemia. In a real-world COPD population, we found that a large number of COPD patients without severe resting hypoxemia were using oxygen therapy, and the use oxygen was affected by factors other than resting oxygenation itself. Further studies, such as the NHLBI Longterm Oxygen Therapy Trial, may be required to determine the long-term effects of oxygen therapy in patients without severe resting hypoxemia. Tables 3 and 4 were not assessed.
